Skip to Main Content
Skip Nav Destination

Online First / Early View

Online first articles are accepted and edited, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI.

Online First

Research Articles October 31 2023
Impact of Liver Fibrosis Severity on Oncological Prognosis in Hepatocellular Carcinoma
Liver Cancer (2023) https://doi.org/10.1159/000533857
Systematic Review October 30 2023
Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection Exhibited Favorable Survival from Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Liver Cancer (2023) https://doi.org/10.1159/000534446
Meta-Analysis October 14 2023
Safety and Efficacy of Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma and Impaired Liver Function: A Systematic Review and Meta-Analysis
Liver Cancer (2023) https://doi.org/10.1159/000533991
Research Articles October 9 2023
Two Distinct Characteristics of Immune Microenvironment in Human Hepatocellular Carcinoma with Wnt/β-Catenin Mutations
Liver Cancer (2023) https://doi.org/10.1159/000533818
Research Articles October 9 2023
Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study
Liver Cancer (2023) https://doi.org/10.1159/000534513
Review Articles October 4 2023
Genetic/Epigenetic Alteration and Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Transforming the Immune Microenvironment with Molecular-Targeted Agents
Liver Cancer (2023) https://doi.org/10.1159/000534443
Editorials October 3 2023
Current Therapeutic Strategies for Hepatocellular Carcinoma in Japan
Liver Cancer (2023) https://doi.org/10.1159/000534304
Research Articles October 1 2023
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma
Liver Cancer (2023) https://doi.org/10.1159/000533425
Research Articles September 30 2023
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Liver Cancer (2023) https://doi.org/10.1159/000533650
Research Articles September 14 2023
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in Lenvatinib
Liver Cancer (2023) https://doi.org/10.1159/000534127
Research Articles August 18 2023
MRI Using Gadoxetic Acid in the Work-Up of Liver Nodules Not Conclusively Benign in Budd-Chiari Syndrome: A Prospective Long-Term Follow-Up
Liver Cancer (2023) https://doi.org/10.1159/000533598
Meta-Analysis July 29 2023
Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis
Liver Cancer (2023) https://doi.org/10.1159/000533166
Meta-Analysis July 25 2023
Balancing Efficacy and Tolerability of First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis
Liver Cancer (2023) https://doi.org/10.1159/000531744
Research Articles July 24 2023
Proton Beam Therapy for Intrahepatic Cholangiocarcinoma: A Multicenter Prospective Registry Study in Japan
Liver Cancer (2023) https://doi.org/10.1159/000531376
Research Articles July 7 2023
Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD
Liver Cancer (2023) https://doi.org/10.1159/000531820
Research Articles July 7 2023
Preoperative Prediction of Microvascular Invasion with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Single Hepatocellular Carcinoma: The Implication of Surgical Decision on the Extent of Liver Resection
Liver Cancer (2023) https://doi.org/10.1159/000531786
Review Articles June 8 2023
Recent Advances in Systemic Therapy for Advanced Intrahepatic Cholangiocarcinoma
Liver Cancer (2023) https://doi.org/10.1159/000531458
Other Types June 5 2023
A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial
Liver Cancer (2023) https://doi.org/10.1159/000531377
Research Articles May 25 2023
Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma
Liver Cancer (2023) https://doi.org/10.1159/000531182
Research Articles May 23 2023
Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma
Liver Cancer (2023) https://doi.org/10.1159/000531176
Research Articles May 15 2023
Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma
Liver Cancer (2023) https://doi.org/10.1159/000530950
Research Articles May 11 2023
Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma
Liver Cancer (2023) https://doi.org/10.1159/000531024
Review Articles April 24 2023
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Liver Cancer (2023) https://doi.org/10.1159/000530700
Research Articles April 17 2023
HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-Related HCC with Distinct Features
Liver Cancer (2023) https://doi.org/10.1159/000530699
Research Articles April 14 2023
Real-Time Fluorescence Imaging to Identify Cholangiocarcinoma in the Extrahepatic Biliary Tree Using an Enzyme-Activatable Probe
Liver Cancer (2023) https://doi.org/10.1159/000530645
Research Articles March 31 2023
Transcatheter Arterial Chemoembolization for Treatment-Naive Hepatocellular Carcinoma Has Different Treatment Effects Depending on Central or Peripheral Tumor Location
Liver Cancer (2023) https://doi.org/10.1159/000530441
Research Articles February 23 2023
Computed Tomography-Defined Sarcopenia in Outcomes of Patients with Unresectable Hepatocellular Carcinoma Undergoing Radioembolization: Assessment with Total Abdominal, Psoas, and Paraspinal Muscles
Liver Cancer (2023) https://doi.org/10.1159/000529676
Research Articles January 19 2023
Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan Criteria
Liver Cancer (2023) https://doi.org/10.1159/000529143
Meta-Analysis December 29 2022
Adverse Events of Immune Checkpoint Inhibitor-Based Therapies for Unresectable Hepatocellular Carcinoma in Prospective Clinical Trials: A Systematic Review and Meta-Analysis
Liver Cancer (2022) https://doi.org/10.1159/000528698

Early View

Editorials November 29 2023
Objective Response to Systemic Therapy is a Strong Predictor of Overall Survival in Patients with Unresectable Hepatocellular Carcinoma
Liver Cancer (2023) https://doi.org/10.1159/000535516
Research Articles November 28 2023
Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 study
Liver Cancer (2023) https://doi.org/10.1159/000535501
Research Articles November 28 2023
A Multicenter Phase 2 Trial Evaluating the Efficacy and Safety of Preoperative Lenvatinib Therapy for Patients with Advanced Hepatocellular Carcinoma (LENS-HCC Trial)
Liver Cancer (2023) https://doi.org/10.1159/000535514
Brief Reports November 13 2023
A Phase 1b Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma: Extended Analysis of Study 116
Liver Cancer (2023) https://doi.org/10.1159/000535154
Review Articles November 13 2023
Second-Line Treatment after Failure of Immune Check Point Inhibitors in Hepatocellular Carcinoma: Tyrosine Kinase Inhibitor, Retrial of Immunotherapy, or Locoregional Therapy?
Liver Cancer (2023) https://doi.org/10.1159/000534303
Research Articles May 25 2023
Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality
Liver Cancer (2023) https://doi.org/10.1159/000530078
Close Modal

or Create an Account

Close Modal
Close Modal